VelosBio Company
VelosBio is a next-generation oncology company, developing novel antibody-drug conjugatesto treat haematological cancers.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
San Diego, California, United States
Founded Date:
2017
Employees Number:
1-10
Funding Status:
M&A
Estimated Revenue:
$1M to $10M
Register and Claim Ownership